Group leader in Integrative Structural Biology

Updated: 3 months ago
Location: Toulouse, MIDI PYRENEES
Job Type: FullTime
Deadline: 14 May 2024

1 Feb 2024
Job Information
Organisation/Company

Centre national de la recherche scientifique
Department

Institute of Pharmacology and Structural Biology
Research Field

Biological sciences » Biology
Researcher Profile

Recognised Researcher (R2)
Country

France
Application Deadline

14 May 2024 - 23:59 (Europe/Paris)
Type of Contract

Permanent
Job Status

Full-time
Hours Per Week

35
Offer Starting Date

1 Jan 2025
Is the job funded through the EU Research Framework Programme?

Not funded by an EU programme
Is the Job related to staff position within a Research Infrastructure?

No

Offer Description

The IPBS-Toulouse launches its annual call for the recruitment of a new group leader.

Asa leading research instituteof the French National Center for Scientific Research (CNRS) and of the University of Toulouse, the Institute of Pharmacology and Structural Biology (IPBS ) conducts state-of-the-art research in cancer biology, immunology, microbiology, structural biology and biophysics. It is a world leader in the discovery, characterization, validation and exploitation of novel pathways and pharmacological targets in the fields of cancer, infection, and inflammation, by combining molecular and cellular biology approaches and in vivo experiments.

Founded in 1996, the IPBS is today composedof17 internationally recognized research groups,bringing together more than 250 scientists and supporting staff, including national and international postdoctoral fellows and PhD students.

The IPBS offers an outstanding scientific and stimulating research environment and benefits from several on-site cutting-edge core facilities including proteomics and structural mass spectrometry, macromolecular crystallography, liquid- and solid-state NMR, biophysical characterization of proteins and complexes (e.g., SEC-MALLS, DLS, nanoDSF, ITC, mass photometry, MST), virtual screening, single particle tracking and tethered particle motion analysis, whole body, tissue and cellular imaging, flow cytometry and cell sorting in standard or BSL3 laboratories and animal facilities. Complementary technologies, including state of the art structural and conventional (cryo-)electron microscopy approaches, high-end sequencing technologies are available in nearby institutes and facilities. The IPBS is located on the main campus of the Université Toulouse III , offering multidisciplinary education in the fields of Science, Health, Engineering and Technology, and developing one of the most important scientific research clusters in France.

In order to reinforce its inspiring, collaborative and cutting-edge environment, the IPBS is seeking a talented group leader using/developing integrative structural biology and biophysical approaches to tackle biological questions that are of key interest to the institute, with priority on:

Microbiology and drug discovery

Structure-function relationship of proteins involved in bacterial virulence and drug resistance. Phenotypic, virtual and biophysical screening of chemical and fragment libraries. Structural and functional characterization of drug-target interactions.

Inflammation and Infection biology

Role of the microenvironment in inflammatory and infectious diseases; impact on treatment. Development, differentiation and migration of immune cells. Antimicrobial immunity and host-pathogen interactions.

Cancer microenvironment and biology

Implication and targeting of stromal components, matrices, metabolism and immune cells in tumor progression, including immuno-therapy. DNA repair and damage response (DDR); DDR-targeted drug discovery; tumor resistance or vulnerabilities to clastogenic agents or DDR modulation.

Outstanding candidates at early-career stage, are expected to develop competitive, independent research and meet the required criteria for successful application to national and international funding, including ATIP-Aveni r, FRM , ANR program , ERC -StG or CoG, or equivalent installation grant, and to a tenured position at CNRS. Senior researchers holding a CNRS or University position are also welcome to apply. The IPBS upholds a commitment to affirmative action and equal opportunity.

Starting package: The successful candidate will be provided with a starting package including office and lab space for 5-6 people as well as technical staff support, seed funding, and mentoring to obtain a tenured position and installation grants. He/she will benefit from free access to on-site technological facilities (imaging, proteomics, structural biology, high throughput screening and animal facilities) and a collaborative and multinational scientific environment, in an ambiance fostering equality, diversity and inclusivity.


Requirements
Research Field
Biological sciences » Biology
Education Level
PhD or equivalent

Languages
ENGLISH
Level
Good

Research Field
Biological sciences » Biology

Additional Information
Selection process

Applications (in English) should be sent before  May 14, 2024 as a single file named LASTNAME_IPBS2024.pdf to [email protected] and should include (i) a cover letter, (ii) a CV with complete list of publications, (iii) 2-3 reference letters (iv) a summary of past achievements (2 pages) and (v) future research project (3 pages).

Tentative calendar

Mid-June: Preselection of candidates

Early-July: Interview of preselected candidates by the international selection committee

Mid-July: Outcome of the selection process

From September: Application for grants and tenured position


Website for additional job details

https://www.ipbs.fr/we-recruit-a-group-leader-in-integrative-structural-biology/

Work Location(s)
Number of offers available
1
Company/Institute
CNRS
Country
France
State/Province
Occitanie
City
Toulouse
Postal Code
31077
Street
205 route de Narbonne
Geofield


Where to apply
E-mail

[email protected]

Contact
City

Toulouse
Website

https://www.ipbs.fr/
Street

205 route de Narbonne
Postal Code

31400
E-Mail

[email protected]
Phone

+33561175835

STATUS: EXPIRED